Hudson Bay Capital Management »

Jazz Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.0M 50k 120.42
2023-12-31 $1.5M 13k 123.00
2023-09-30 $4.9M 38k 129.44
2021-09-30 $2.3M 18k 130.23

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Eli Lilly & Co. Put Option (LLY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dollar Tree Put Option (DLTR)
Brookfield Corp Cl A Ltd Vt Sh Put Option (BN)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Meta Platforms Cl A Put Option (META)
Broadcom Put Option (AVGO)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Vestal Point Capital
Polaris Capital Management
Baupost Group
Dimensional Fund Advisors
Geode Capital Management
Franklin Resources
Renaissance Technologies
EcoR1 Capital
Swedbank AB
Thompson, Siegel, & Walmsley

View all funds holding Jazz Pharmaceuticals